Nick Brandon

Company: Neumora

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Reframing Muscarinic Modulation: Lessons from Trials, Selectivity Challenges & the Placebo Puzzle 10:00 am

Explore real-world clinical trial insights, including implications of placebo response and operational variability on muscarinic agent outcomes. Discuss the evolving understanding of M1 vs. M4 receptor agonism and their roles in achieving therapeutic efficacy in schizophrenia.Read more

day: Day One

Roundtable Discussion: Benchmarking Opportunities, Risks & Challenges of Studying & Therapeutically Targeting Psychotic Symptoms in Dementia, Bipolar, PTSD, Depression, Autism, ADHD & More 5:00 pm

Practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas: Dementia-Associated Psychosis Bipolar Augmentation Strategies Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and open a wider audience debate. Read more

day: Day One